| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvants, endocrines and conserved epitopes; factors to consider when designing “herapeutic vaccines”
|
Rook, G.A.W.
|
|
1995
|
17 |
2 |
p. 91-102
12 p.
|
artikel
|
| 2 |
An invitation to join the International Society for Immunopharmacology
|
|
|
1995
|
17 |
2 |
p. i-
1 p.
|
artikel
|
| 3 |
Clinical activity of leukotriene inhibitors
|
Harris, Richard R.
|
|
1995
|
17 |
2 |
p. 147-156
10 p.
|
artikel
|
| 4 |
DNA vaccines: A novel approach to immunization
|
Fynan, Ellen F.
|
|
1995
|
17 |
2 |
p. 79-83
5 p.
|
artikel
|
| 5 |
Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide
|
Bahr, George M.
|
|
1995
|
17 |
2 |
p. 117-131
15 p.
|
artikel
|
| 6 |
Interleukin-8 and the chemokine family
|
Baggiolini, Marco
|
|
1995
|
17 |
2 |
p. 103-108
6 p.
|
artikel
|
| 7 |
Low molecular weight immunomodulators produced by microorganisms
|
Ishizuka, Masaaki
|
|
1995
|
17 |
2 |
p. 133-139
7 p.
|
artikel
|
| 8 |
New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130
|
Manolagas, Stavros C.
|
|
1995
|
17 |
2 |
p. 109-116
8 p.
|
artikel
|
| 9 |
Present status of vaccination against HIV-1 infection
|
Girard, Marc
|
|
1995
|
17 |
2 |
p. 75-78
4 p.
|
artikel
|
| 10 |
The role of adjuvants in retroviral vaccines
|
Vogel, Frederick R.
|
|
1995
|
17 |
2 |
p. 85-90
6 p.
|
artikel
|
| 11 |
TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
|
Elliott, M.J.
|
|
1995
|
17 |
2 |
p. 141-145
5 p.
|
artikel
|
| 12 |
Tumor vaccines: Effects and fate of IL-2 transfected murine melanoma cells in vivo
|
Maass, G.
|
|
1995
|
17 |
2 |
p. 65-67
3 p.
|
artikel
|
Tijdschrift beschrijving